Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > US flu activity soars; hospital cases nearly double

<< Previous

Bullboard Posts

Next >>

Comment by SimonSaidon Dec 03, 2022 3:38pm

179 Views

Post# 35148837

RE:RE:RE:US flu activity soars; hospital cases nearly double

When all is said and done, lots gets said and nothing gets done...the time for a leadership change has passed, long ago.

The question to be asked is does the PMX filter work? If so, why the delay in enrolment? The posts can keep referencing other studies, trial design and the expected windfall once approved...where's the support by way of news.

IMHO

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec